BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 16895524)

  • 1. Tumour suppressor p53 down-regulates the expression of the human hepatocyte nuclear factor 4alpha (HNF4alpha) gene.
    Maeda Y; Hwang-Verslues WW; Wei G; Fukazawa T; Durbin ML; Owen LB; Liu X; Sladek FM
    Biochem J; 2006 Dec; 400(2):303-13. PubMed ID: 16895524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of hepatic nuclear factor 4alpha on expression of human hepatic stimulator substance via its action on the proximal promoter in HepG2 cells.
    Guo D; Dong LY; Wu Y; Yang L; An W
    Biochem J; 2008 Oct; 415(1):111-21. PubMed ID: 18513187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCAAT-enhancer binding protein-α (C/EBPα) and hepatocyte nuclear factor 4α (HNF4α) regulate expression of the human fructose-1,6-bisphosphatase 1 (FBP1) gene in human hepatocellular carcinoma HepG2 cells.
    Wattanavanitchakorn S; Rojvirat P; Chavalit T; MacDonald MJ; Jitrapakdee S
    PLoS One; 2018; 13(3):e0194252. PubMed ID: 29566023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte nuclear factor 4α regulates the expression of the murine pyruvate carboxylase gene through the HNF4-specific binding motif in its proximal promoter.
    Chavalit T; Rojvirat P; Muangsawat S; Jitrapakdee S
    Biochim Biophys Acta; 2013 Oct; 1829(10):987-99. PubMed ID: 23665043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ING1 represses transcription by direct DNA binding and through effects on p53.
    Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
    Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel mechanisms of regulation of the expression and transcriptional activity of hepatocyte nuclear factor 4α.
    Guo S; Lu H
    J Cell Biochem; 2019 Jan; 120(1):519-532. PubMed ID: 30191603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear receptor hepatocyte nuclear factor 4alpha1 competes with oncoprotein c-Myc for control of the p21/WAF1 promoter.
    Hwang-Verslues WW; Sladek FM
    Mol Endocrinol; 2008 Jan; 22(1):78-90. PubMed ID: 17885207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of glucocorticoid receptor and hepatocyte nuclear factor 4alpha (HNF4alpha) binding to the hnf4alpha gene in the liver.
    Bailly A; Briançon N; Weiss MC
    Biochimie; 2009 Sep; 91(9):1095-103. PubMed ID: 19540905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repression of hepatocyte nuclear factor 4alpha tumor suppressor p53: involvement of the ligand-binding domain and histone deacetylase activity.
    Maeda Y; Seidel SD; Wei G; Liu X; Sladek FM
    Mol Endocrinol; 2002 Feb; 16(2):402-10. PubMed ID: 11818510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional activation of CYP2C9, CYP1A1, and CYP1A2 by hepatocyte nuclear factor 4alpha requires coactivators peroxisomal proliferator activated receptor-gamma coactivator 1alpha and steroid receptor coactivator 1.
    Martínez-Jiménez CP; Castell JV; Gómez-Lechón MJ; Jover R
    Mol Pharmacol; 2006 Nov; 70(5):1681-92. PubMed ID: 16882880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulated expression of P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha in the pathogenesis of human cancer.
    Tanaka T; Jiang S; Hotta H; Takano K; Iwanari H; Sumi K; Daigo K; Ohashi R; Sugai M; Ikegame C; Umezu H; Hirayama Y; Midorikawa Y; Hippo Y; Watanabe A; Uchiyama Y; Hasegawa G; Reid P; Aburatani H; Hamakubo T; Sakai J; Naito M; Kodama T
    J Pathol; 2006 Apr; 208(5):662-72. PubMed ID: 16400631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HBx inhibits CYP2E1 gene expression via downregulating HNF4α in human hepatoma cells.
    Liu H; Lou G; Li C; Wang X; Cederbaum AI; Gan L; Xie B
    PLoS One; 2014; 9(9):e107913. PubMed ID: 25238230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis signal-regulating kinase 1 mediates the inhibitory effect of hepatocyte nuclear factor-4α on hepatocellular carcinoma.
    Jiang CF; Wen LZ; Yin C; Xu WP; Shi B; Zhang X; Xie WF
    Oncotarget; 2016 May; 7(19):27408-21. PubMed ID: 27050273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EPS15R, TASP1, and PRPF3 are novel disease candidate genes targeted by HNF4alpha splice variants in hepatocellular carcinomas.
    Niehof M; Borlak J
    Gastroenterology; 2008 Apr; 134(4):1191-202. PubMed ID: 18395097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus suppresses Hepatocyte Nuclear Factor 4 alpha, a key regulator of hepatocellular carcinoma.
    Vallianou I; Dafou D; Vassilaki N; Mavromara P; Hadzopoulou-Cladaras M
    Int J Biochem Cell Biol; 2016 Sep; 78():315-326. PubMed ID: 27477312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of a plasmid vector for liver-specific inhibition of hepatocyte nuclear factor 4 alpha expression.
    Song XQ; Chen EQ; Wang YB; Zhou TY; Liu L; Liu C; Cheng X; Tang H
    Plasmid; 2012 Jan; 67(1):60-6. PubMed ID: 21907733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fuse binding protein antagonizes the transcription activity of tumor suppressor protein p53.
    Dixit U; Liu Z; Pandey AK; Kothari R; Pandey VN
    BMC Cancer; 2014 Dec; 14():925. PubMed ID: 25487856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis.
    Sayeed A; Konduri SD; Liu W; Bansal S; Li F; Das GM
    Cancer Res; 2007 Aug; 67(16):7746-55. PubMed ID: 17699779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of hepatocyte proliferation by hepatocyte nuclear factor 4α in adult mice.
    Bonzo JA; Ferry CH; Matsubara T; Kim JH; Gonzalez FJ
    J Biol Chem; 2012 Mar; 287(10):7345-56. PubMed ID: 22241473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of hepatocyte nuclear factor 4 alpha in transcriptional regulation of the human pregnane X receptor gene in the human liver.
    Iwazaki N; Kobayashi K; Morimoto K; Hirano M; Kawashima S; Furihata T; Chiba K
    Drug Metab Pharmacokinet; 2008; 23(1):59-66. PubMed ID: 18305375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.